Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) Short Interest Up 625.5% in February

Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) was the target of a significant growth in short interest in February. As of February 15th, there was short interest totalling 37,000 shares, a growth of 625.5% from the January 31st total of 5,100 shares. Based on an average daily volume of 82,800 shares, the short-interest ratio is currently 0.4 days.

Algernon Pharmaceuticals Stock Performance

AGNPF opened at $0.06 on Friday. Algernon Pharmaceuticals has a twelve month low of $0.04 and a twelve month high of $0.12. The company has a 50-day moving average price of $0.06 and a 200 day moving average price of $0.06.

About Algernon Pharmaceuticals

Algernon Pharmaceuticals Inc operates as a clinical stage pharmaceutical development company. It focuses on the areas of non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, pancreatic and small cell lung cancer, and acute lung injury in Canada and Australia.